It is well known that CP patients with PRSS1 or SPINK1 gene mutations belong to a high-risk group for pancreatic cancer, with an estimated risk 53–87 times higher than the normal population [37,69,70]. Here, SPINK1 is linked to pancreatic neoplasm.